The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications
- 1 July 2000
- journal article
- case report
- Published by Elsevier in Thrombosis Research
- Vol. 99 (1) , 21-24
- https://doi.org/10.1016/s0049-3848(00)00220-6
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Treatment of Patients with Factor VIII and Factor IX Inhibitors with Special Focus on the Use of Recombinant Factor VIIaThrombosis and Haemostasis, 1999
- Safety, efficacy and lessons from continuous infusion with rFVIIaHaemophilia, 1998
- Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitorsAmerican Journal of Hematology, 1994
- Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa)Blood Coagulation & Fibrinolysis, 1993